Clinical Trial Update: A Study of SHR-A1811 in Subjects With Ovarian Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating SHR-A1811 for ovarian cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• SHR-A1811

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Ovarian Cancer | Phase 3 | Status: RECRUITING